We are live on ! Find out more
AFM

Anson Funds Management Portfolio holdings

AUM $1.68B
1-Year Est. Return 373.57%
This Fund
S&P 500
This Quarter Est. Return
-8.42%
1 Year Est. Return
+373.57%
3 Year Est. Return
+2,009.68%
5 Year Est. Return
+1,118.82%
10 Year Est. Return
+17,700.84%
AUM
$136M
AUM Growth
-$70.3M
Cap. Flow
-$13.5M
Cap. Flow %
-9.92%
Top 10 Hldgs %
88.94%
Holding
54
New
15
Increased
5
Reduced
4
Closed
20

Top Buys

Rank Stock Value
1
SRAX
SRAX, Inc. Class A Common Stock
SRAX
+$3.34M
2
DMK
DMK Pharmaceuticals Corporation Common Stock
DMK
+$1.48M
3
BPY
Brookfield Property Partners L.P. Limited Partnership Units
BPY
+$1.35M
4
VRE
Veris Residential
VRE
+$1.33M
5
AIM
AIM ImmunoTech
AIM
+$1.25M

Top Sells

Rank Stock Value
1
BHC icon
Bausch Health
BHC
+$14.7M
2
OR icon
OR Royalties Inc
OR
+$4.01M
3
BPYU
Brookfield Property REIT Inc. Class A Common Stock
BPYU
+$2.27M
4
HBM icon
Hudbay
HBM
+$2M
5
PRVB
Provention Bio, Inc. Common Stock
PRVB
+$1.93M

Sector Composition

Rank Sector Weight
1 Miscellaneous 83.05%
2 Real Estate 7.86%
3 Consumer Staples 2.47%
4 Industrials 2.04%
5 Communication Services 1.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SHIPZ
26
DELISTED
Seanergy Maritime Holdings Corp Class B Warrant
SHIPZ
$351K 0.26%
+730,000
New +$135K
NSPRZ
27
DELISTED
InspireMD, Inc. Series B Warrants
NSPRZ
$325K 0.24%
250,000
– –
RESI
28
DELISTED
Front Yard Residential Corporation Common Stock
RESI
$289K 0.21%
+25,000
New +$289K
TOON icon
29
Kartoon Studios
TOON
$36.1M
$286K 0.21%
+44,573
New +$386K
SNR
30
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
$167K 0.12%
+25,000
New +$166K
PHIOW
31
DELISTED
Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021
PHIOW
$60K 0.04%
217,023
– –
MDGSW
32
DELISTED
Medigus Ltd. Series C Warrant
MDGSW
$36K 0.03%
21,000
+5,375
+34% +$2.59K
CHGA
33
Change Agents Corp
CHGA
$2.27M
– –
-39
Closed -$307K
BHC icon
34
Bausch Health
BHC
$2.21B
– –
-581,569
Closed -$14.7M
COLD icon
35
Americold
COLD
$4.17B
– –
-10,000
Closed -$324K
CRVO icon
36
CervoMed
CRVO
$38.3M
– –
-4,365
Closed -$933K
HBM icon
37
Hudbay
HBM
$11.4B
– –
-370,000
Closed -$2M
HST icon
38
Host Hotels & Resorts
HST
$15.2B
– –
-53,500
Closed -$975K
IGC icon
39
IGC Pharma
IGC
$28.5M
– –
-94,353
Closed -$155K
INVH icon
40
Invitation Homes
INVH
$16.3B
– –
-18,439
Closed -$493K
LGMK
41
DELISTED
LogicMark
LGMK
– –
-398
Closed -$1.47M
NUWE icon
42
Nuwellis
NUWE
$2.53M
– –
0
– -$278K
OR icon
43
OR Royalties Inc
OR
$6.75B
– –
-375,000
Closed -$4.01M
PLD icon
44
Prologis
PLD
$128B
– –
-8,500
Closed -$681K
SHIP icon
45
Seanergy Maritime Holdings
SHIP
$399M
– –
-1,644
Closed -$163K
SLS icon
46
SELLAS Life Sciences
SLS
$2.37B
– –
-9,275
Closed -$52K
SONN
47
DELISTED
Sonnet BioTherapeutics
SONN
– –
-3
Closed -$214K
TLRY icon
48
CALL
Tilray
TLRY
$570M
– –
-8,900
Closed -$4.14M
VUZI icon
49
PUT
Vuzix
VUZI
$209M
– –
-169,200
Closed -$692K
PRVB
50
DELISTED
Provention Bio, Inc. Common Stock
PRVB
– –
-159,337
Closed -$1.93M
1
2
3

Similar funds

MCM
Maple Capital Management Montpelier, Vermont $1.68B AUM 27.38% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return
KFGK
Keystone Financial Group (Kentucky) Lexington, Kentucky $1.69B AUM 40.17% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BCAM
Boston Common Asset Management Boston, Massachusetts $1.69B AUM 28.29% 1-Year Est. Return
CWG
Cornerstone Wealth Group Huntersville, North Carolina $1.69B AUM 28.24% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

Anson Funds Management's Q3 2019 Portfolio in Review

As of Q3 2019, Anson Funds Management held 54 positions worth $136M, down 34% from $207M the previous quarter. Its ten largest holdings account for 89% of the portfolio.

Anson Funds Management withdrew a net $13.5M in Q3 2019, closing 20 positions and reducing 4 holdings. Its most notable exit was Bausch Health, an estimated $14.7M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, up from 71% a quarter earlier, followed by Real Estate and Consumer Staples.

Against the trend, Anson Funds Management opened a new position in SRAX, Inc. Class A Common Stock worth $2.12M.

  • Anson Funds Management's largest Q3 2019 buy was SRAX, Inc. Class A Common Stock: 923,626 shares worth $2.12M.
  • Anson Funds Management added most to Veris Residential in Q3 2019, an estimated $1.33M increase.
  • Anson Funds Management's biggest Q3 2019 reduction was Argan, cutting an estimated $1.41M.
  • Anson Funds Management fully exited Bausch Health in Q3 2019, selling an estimated $14.7M.
  • Anson Funds Management's ten largest holdings make up 89% of its $136M portfolio in Q3 2019.
  • Anson Funds Management opened 15 new positions and closed 20 in Q3 2019.
  • Anson Funds Management's portfolio value fell 34% quarter-over-quarter to $136M.

Based on Anson Funds Management's 13F filing for Q3 2019, filed 14 Nov 2019.